关于非小细胞肺癌化疗的患者观点和副作用经验:一种定性研究
Hafiz Muhammad Zubair1, Muhammad Arslan Khan2, Faisal Gulzar1
1Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan.
Cancer management and research
|May 31, 2023
概括
接受非小细胞肺癌 (NSCLC) 缓解化疗的患者面临挑战,但适应,经历受到副作用,信念和支持系统的影响. 这项定性研究提供了对他们的旅程的见解.
科学领域:
- 在瘤学瘤学.
- 定性研究是指质量研究.
- 患者体验 患者体验
背景情况:
- 息化疗是非小细胞肺癌 (NSCLC) 的关键治疗方法.
- 了解患者的经验对于改善护理和支持至关重要.
- 关于在巴基斯坦接受缓性化疗的NSCLC患者生活经验的研究有限.
研究的目的:
- 探索患者对NSCLC缓和化疗的经验.
- 了解患者如何适应化疗后的生活.
- 调查患者在治疗期间的信念和生活质量.
主要方法:
- 探索性描述性的定性方法.
- 与22名完成化疗的NSCLC患者进行半结构面试.
- 在巴基斯坦进行的面对面采访.
主要成果:
- 出现在关键的主题:医院环境,替代治疗信仰,应对机制 (正面/负面),生活视角和医疗保险.
- 患者报告了显著的化疗副作用,但完成了他们的治疗疗程.
- 这项研究更深入地了解了以前研究不足的NSCLC患者经验.
结论:
- 调查结果可以帮助医疗保健提供者做出治疗决策和共同决策.
- 对患者体验的更好理解可以带来更好的临床结果.
- 这项研究强调了解决患者信仰和支持系统的重要性.
更多相关视频
相关概念视频
Nursing Ethical Principles II
1.0K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.0K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
256
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
256
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
210
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
210
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
359
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
359
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
328
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
328


